HOME >> MEDICINE >> NEWS
Treatment discovered for deadly childhood disease

ST. PAUL, Minn -- Researchers have discovered that a treatment involving enzyme replacement therapy dramatically reduces the risk of death in children with Pompe disease, a rare genetic disorder in which most children die before their first birthday. The disorder causes profound muscle weakness and heart and breathing problems and affects as many as one in 40,000 births. The study is published in the online edition of Neurology, the scientific journal of the American Academy of Neurology.

"This form of treatment has changed the natural history of this otherwise lethal disease," said study author Priya Sunil Kishnani, MD, with Duke University in Durham, North Carolina.

The year long study involved 18 children under the age of six months with rapidly progressing Pompe disease. Pompe disease is caused by a deficiency in the enzyme acid a-glucosidase (GAA), which is needed to break down glycogen, a complex sugar molecule which releases glucose.

The study found all 18 children who started to receive the enzyme replacement, recombinant human GAA (rhGAA), before they were six months old survived to at least 18 months of age. Fifteen of the 18 children also did not need a ventilator. The study showed that starting rhGAA before the age of six months reduced the risk of death in children by 99 percent, reduced the risk of death or invasive breathing assistance by 92 percent, and reduced the risk of death or any type of ventilation by 88 percent, compared to past patients without this treatment.

"This form of enzyme replacement therapy markedly extended survival and improved respiratory performance in these children, with a majority of them showing normal growth and substantial gains in motor development," said Kishnani. "rhGAA is safe and the only effective treatment for Pompe disease; it is life saving."

Kishnani said the young age at which the children began treatment may have contributed to their improved response comp
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
6-Dec-2006


Page: 1 2

Related medicine news :

1. Treatment for early prostate cancer associated with type of specialist seen
2. Treatment outcomes of patients with HIV and tuberculosis
3. Treatment of kidney condition requires an individualized approach
4. Treatment of in-hospital cardiac patients is focus of Jefferson University presentations
5. Treatment for homeless youth pays off in long run, study finds
6. Treatment developed for patients with medically unexplained symptoms
7. Treatment drug may cause jawbone to die
8. Treatment for anorexia nervosa appears to have improved outcome
9. Treatment reduces gastric ulcers in at-risk patients using long-term NSAIDS
10. North Central Cancer Treatment Group finding ways to make treatment easier
11. Treatment of severe coronary artery disease with drug-eluting stents a viable alternative to CABG

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2019)... ... 08, 2019 , ... Intelligent.com, a trusted resource for online ... Programs for 2020. The comprehensive research guide is based on an assessment of ... on curriculum quality, graduation rate, reputation, and post-graduate employment. , The 2020 ...
(Date:12/6/2019)... ... December 06, 2019 , ... Connecticut is home ... excellence in patient care. On December 12th, Hartford Business Journal will recognize eight ... Care Heroes Awards at the Hartford Marriott. , “We are fortunate to have ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... HIPAA compliance solution for the Wyoming Medical Society. Compliancy Group is dedicated to ... entities have an obligation to adhere to the standards set forth by the ...
(Date:12/5/2019)... ... December 05, 2019 , ... A cohort of ... technology to help their patients more easily detect ruptured silicone gel implants. Dr. ... study and reporting on his experience. While the FDA currently recommends regular MRI ...
(Date:12/5/2019)... , ... December 05, 2019 , ... ... milestones ranging from launching exceptional products that help people embrace, achieve, and maintain ... , “We’ve never been more committed to our mission of impacting world health, ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... on development of treatments for psychiatric and neurodegenerative disorders, announced today that the ... application for NBTX-001 Inhaler, allowing the Company to initiate its Phase 2b trial ...
(Date:12/6/2019)... GILBERT, Ariz. (PRWEB) , ... December 06, 2019 ... ... the Industry Nutrition Forum in Philadelphia to share information and ideas about working ... percentage of the population. , “It’s vital that we develop a healthy and ...
(Date:12/6/2019)... , ... December 06, 2019 , ... ... agreement with Forbidden Fruit Garden Supply LLC (a division of Horticultural Holdings LLC) ... clientele of professional growers. , FFGS is a team of disciplined and ...
Breaking Medicine Technology:
Cached News: